factual

Atenolol Lowers BP But Not Outcomes

Atenolol (marketed as Tenormin) lowers blood pressure as well as most other antihypertensives, but pooled placebo-controlled studies show it does not improve mortality or heart attack risk and only slightly reduces stroke risk, illustrating that a drug can succeed on the surrogate endpoint yet fail on clinical endpoints.

factualpending

Speaker

Adam Cifu

Evidence Quote

“it doesn't improve mortality. Doesn't improve the risk of heart attacks.”

Source

Adam Cifu on Ending Medical Reversal— EconTalk
Created: 6/13/2026, 12:11:12 AM

Your notes

Loading notes...